I begge undersøgelser havde patienter, der fik icatibant, en hurtigere mediantid til symptomlindring (henholdsvis 2, 0 og 2, 5 timer) i forhold til tranexaminsyre (12, 0 timer) og placebo (4, 6 timer).
In both studies, patients on icatibant had a faster median time to onset of symptom relief (2.0 and 2.5 hours, respectively) compared to tranexamic acid (12.0 hours) and placebo (4.6 hours).